Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Gobbi

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Neurobiology of Disease|December 9, 2009
Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmissionFrancis Rodriguez Bambico, Nhu-Tram Nguyen, Noam Katz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 6, 2013
Father absence in the monogamous california mouse impairs social behavior and modifies dopamine and glutamate synapses in the medial prefrontal cortexFrancis R Bambico, Baptiste Lacoste, Patrick R Hattan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 10, 2016
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampusFrancis R Bambico, Andrea Duranti, José N Nobrega, et al.
Current Pharmaceutical Design|May 16, 2009
Endocannabinoids in the treatment of mood disorders: evidence from animal modelsFrancis Rodriguez Bambico, Andrea Duranti, Andrea Tontini, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 6, 2012
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmissionFrancis Rodriguez Bambico, Patrick R Hattan, Jean-Philippe Garant, et al.
Journal of Clinical Psychopharmacology|November 6, 2023
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality DisordersChristophe Moderie, Jacob D King, Nicolas Nuñez, et al.
Transcultural Psychiatry|October 20, 2022
Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practiceGabriella Gobbi, Antonio Inserra, Kyle T Greenway, et al.
Neurochemistry International|October 12, 2007
An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET studyAlexandre Berney, Masami Nishikawa, Chawki Benkelfat, et al.
Journal of Psychiatry & Neuroscience : JPN|June 3, 2004
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic responsePierre Blier, Gabriella Gobbi, Nasser Haddjeri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 31, 2023
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphineLeora Pearl-Dowler, Luca Posa, Martha Lopez-Canul, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Neurobiology of Disease|December 9, 2009
Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmissionFrancis Rodriguez Bambico, Nhu-Tram Nguyen, Noam Katz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 6, 2013
Father absence in the monogamous california mouse impairs social behavior and modifies dopamine and glutamate synapses in the medial prefrontal cortexFrancis R Bambico, Baptiste Lacoste, Patrick R Hattan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 10, 2016
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampusFrancis R Bambico, Andrea Duranti, José N Nobrega, et al.
Current Pharmaceutical Design|May 16, 2009
Endocannabinoids in the treatment of mood disorders: evidence from animal modelsFrancis Rodriguez Bambico, Andrea Duranti, Andrea Tontini, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 6, 2012
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmissionFrancis Rodriguez Bambico, Patrick R Hattan, Jean-Philippe Garant, et al.
Journal of Clinical Psychopharmacology|November 6, 2023
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality DisordersChristophe Moderie, Jacob D King, Nicolas Nuñez, et al.
Transcultural Psychiatry|October 20, 2022
Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practiceGabriella Gobbi, Antonio Inserra, Kyle T Greenway, et al.
Neurochemistry International|October 12, 2007
An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET studyAlexandre Berney, Masami Nishikawa, Chawki Benkelfat, et al.
Journal of Psychiatry & Neuroscience : JPN|June 3, 2004
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic responsePierre Blier, Gabriella Gobbi, Nasser Haddjeri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 31, 2023
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphineLeora Pearl-Dowler, Luca Posa, Martha Lopez-Canul, et al.
Pageof 12